&nbsp;

FactsAboutSmokingCOVID-19CancerTreatment.pdf

Jan 2021

Document

FactsAboutSmokingCOVID-19CancerTreatment-FR.pdf

Jan 2021

Document

ColonOPNPReferralForm.docx

Jan 2021

Ce que vous devez savoir au sujet des vaccins contre la COVID-19 : Renseignements destinés aux personnes atteintes d’un cancer

Document

CancerPatientsandCOVIDVaccinesFAQ.pdf

Feb 2021

Document

CancerPatientsandCOVIDVaccinesFAQ-FR.pdf

Feb 2021

Regimen

CEDADECI

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

Exceptional Access Program

decitabine / cedazuridine - For the treatment of adult patients with myelodysplastic syndromes (MDS), according to clinical criteria

decitabine / cedazuridine

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

CRBPNPAC

Cancer Type:

Gynecologic,

Cervix,

Endometrial,

Ovary

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel,

CARBOplatin

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

CRBPNPAC

Cancer Type:

Gynecologic,

Endometrial,

Ovary

Intent: Adjuvant, Curative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel,

CARBOplatin

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

CYCLVINO

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Adjuvant, Curative

Drugs Used:

vinorelbine,

cyclophosphamide

Quick Link(s):

Regimen Monograph

Feb 2021

Regimen

CISPETOP+DURV

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Durvalumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used: